Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

Scientists from Skoltech and the University of Potsdam have developed a physical theory that sheds light on how molecular ...

Amazon has reportedly developed an artificial intelligence platform called Bio Discovery, designed to help drug researchers ...

Heterogeneous NPU designs bring together multiple specialized compute engines to support the range of operators required by ...

Artificial intelligence (AI) and machine learning (ML) systems have become central to modern data-driven decision-making. They are now widely applied in fields as diverse as healthcare, finance, ...

The more we rely on AI, without oversight or validation, the greater our exposure is to making critical decisions based on ...

Freddie Mac and Fannie Mae have respectively released a mix of new flexibilities and requirements for single-family mortgages they purchase as April has gotten underway. Processing Content Fannie is ...

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal ...

In the spring of 2020, the Federal Reserve faced a challenge: The COVID-19 pandemic was upending daily life with shutdowns, social distancing, and heightened uncertainty, but the traditional economic ...

Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data faster. The Indexing and retrievals are way faster 10-40X faster in most ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...